Itch, Skin Pain and Work Impairment in 265 Japanese Adults

Doctor’s Notes · Life in Motion · Evidence Review

Editorial disclosure: The featured image is an AI-created illustration of a fictional work or daily-life scene. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.

Study snapshot

What does the result mean?

The itch-plus-pain group had 14.5 percentage points more overall work impairment than the reference group (P=0.034), alongside worse POEM and more sleep disruption.

The denominator changes across the paper: 265 patients were surveyed, while the three reported symptom groups total 186. A responsible reading keeps the analysis subgroup separate from the enrollment total.

The denominator is part of the finding. A clinic sample, compensation registry, online panel or selected occupational group answers a different question from a random general-population cohort. Percentages should remain attached to the people actually studied.

What the study cannot establish

Only 26 participants were in the combined symptom group, group counts do not account for every enrolled patient, symptoms were not randomized, and residual confounding is likely.

Observational association is not the same as causation. Even when an odds ratio or confidence interval is reported, unmeasured exposure, access to care, reporting practices and selection can influence the estimate. A PubMed record is a bibliographic source; PubMed indexing is not NIH endorsement of the study, this interpretation or any product.

Why job title is not enough

Two people with the same occupation may have different contact with water, cleansers, gloves, resins, metals, food proteins, dust, friction or heat. Conversely, the same exposure can appear at work, during caregiving, hobbies or household tasks. A useful history records the task, material, route, duration and timing—not only the job name.

Symptoms, clinical examination and patch testing answer different questions. A symptom survey may detect a pattern. An examination can refine the differential diagnosis. Patch testing looks for delayed contact sensitization, while immediate reactions may need different evaluation. Occupational relevance still depends on real exposure and timing.

Practical questions to document

• Which exact task, product, glove, metal, resin, cleanser, food, plant, dust or surface preceded the change?
• Where did symptoms appear and how did they change on days away, after process changes or after different protective equipment?
• How often were hands washed, occluded, rubbed, heated, cooled or kept wet?
• Did symptoms affect sleep, dexterity, attendance, pace, safety or the ability to complete a specific task?
• Can labels and safety-data sheets be brought to occupational health without deliberately placing workplace material on skin?

Prevention comes before cosmetic care

Substitution, engineering controls, exposure reduction, training and correctly selected protective equipment are core workplace measures. Gloves are not automatically protective: material, fit, breakthrough time, sweating and glove allergens matter. A moisturizer cannot neutralize an allergen, replace ventilation or make an unsafe process safe.

Seek professional evaluation for persistent, recurrent or spreading symptoms, drainage, fever, breathing symptoms, severe pain, rapidly worsening redness or major loss of function. Individual diagnosis and workplace accommodation require a clinician and, when relevant, occupational health.

Primary research and authoritative guidance

• Primary research record: PubMed PMID 35787197
• NIOSH: occupational skin exposure
• NIAMS: atopic dermatitis overview
• American Academy of Dermatology: eczema skin care

Where a cosmetic moisturizer fits

Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, relieves pain or itch, is appropriate for every person, or provides pediatric or 24-hour efficacy.

Continue the evidence series

• Pruritus and Work Impairment in 370 Employed Japanese Adults With Atopic Dermatitis
• Quality of Life and Depression in 758 Recognized Occupational Hand-Eczema Cases
• Occupational Characteristics in 662 Korean Adults With Atopic Dermatitis
• Sick Leave and Job Change in 199 Swiss Adults With Chronic Hand Eczema

Evidence note: This educational article separates reported findings from interpretation and does not provide diagnosis, treatment or a workplace-safety determination.